Study: Slow Release Ketamine Tablets Effective in Treating Severe Depression
A new study shows that slow-release ketamine tablets are effective in treating severe depression. Exciting news for at-home treatment.
Read More
A new study shows that slow-release ketamine tablets are effective in treating severe depression. Exciting news for at-home treatment.
Read More
Could ketamine help alleviate fibromyalgia pain? Previous studies only provided a short term solution. But that may have changed.
Read More
A new study has discovered that a single dose of psilocybin reshapes the brains of healthy adults with no previous
Read More
What's the world's most powerful mushroom? Let's look back when Paul Stamets took us on a walk in the woods
Read More
Johns Hopkins Medicine recommends psychedelics research guidelines. And is leading efforts to refine key areas of psychedelic research.
Read More
If the current trajectory holds, J&J's Spravato could reach up to 3.5 billion dollars in annual sales by 2028.
Read More
More than 49,000 Americans died by suicide in 2022, representing a 3% jump over the previous year and the highest
Read More
The FDA has granted Breakthrough Therapy designation to BPL-003, a nasal spray that could transform treatment for patients whose depression
Read More
Psilocybin has shown promise for treating depression, but its hallucinogenic effects create barriers. A new study may change that.
Read More
SoundSelf uses immersive biofeedback technology to enhance ketamine and Spravato treatments, improving patient outcomes, retention, and clinic revenue.
Read More